Emerging links between E2F control and mitochondrial function

• Published in: Cancer research (Chicago, Ill.) Vol. 75; no. 4; pp. 619 - 623
• Main Authors: Benevolenskaya, Elizaveta V, Frolov, Maxim V
• Format: Journal Article
• Language: English
• Published: United States 15.02.2015
• Subjects: Apoptosis - genetics; Cell Cycle Checkpoints - genetics; Cell Survival - genetics; E2F Transcription Factors - biosynthesis; E2F Transcription Factors - genetics; E2F Transcription Factors - metabolism; Gene Expression Regulation, Neoplastic; Humans; Mitochondria - genetics; Mitochondria - pathology; Neoplasms - genetics; Neoplasms - pathology; Retinoblastoma Protein - biosynthesis; Retinoblastoma Protein - genetics; Retinoblastoma Protein - metabolism; Transcription, Genetic; Tumor Suppressor Protein p53 - genetics
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.can-14-2173

The family of E2F transcription factors is the key downstream target of the retinoblastoma tumor suppressor protein (pRB), which is frequently inactivated in human cancer. E2F is best known for its role in cell-cycle regulation and triggering apoptosis. However, E2F binds to thousands of genes and, thus, could directly influence a number of biologic processes. Given the plethora of potential E2F targets, the major challenge in the field is to identify specific processes in which E2F plays a functional role and the contexts in which a particular subset of E2F targets dictates a biologic outcome. Recent studies implicated E2F in regulation of expression of mitochondria-associated genes. The loss of such regulation results in severe mitochondrial defects. The consequences become evident during irradiation-induced apoptosis, where E2F-deficient cells are insensitive to cell death despite induction of canonical apoptotic genes. Thus, this novel function of E2F may have a major impact on cell viability, and it is independent of induction of apoptotic genes. Here, we discuss the implications of these findings in cancer biology.